Skip Navigation
American College of Physicians Logo
  • Subscribe
  • Submit a Manuscript
  • Sign In
    Sign in below to access your subscription for full content
    INDIVIDUAL SIGN IN
    Sign In|Set Up Account
    You will be directed to acponline.org to register and create your Annals account
    INSTITUTIONAL SIGN IN
    Open Athens|Shibboleth|Log In
    Annals of Internal Medicine
    SUBSCRIBE
    Subscribe to Annals of Internal Medicine.
    You will be directed to acponline.org to complete your purchase.
Annals of Internal Medicine Logo Menu
  • Latest
  • Issues
  • Channels
  • CME/MOC
  • In the Clinic
  • Journal Club
  • Web Exclusives
  • Author Info
Advanced Search
  • ‹ PREV ARTICLE
  • This Issue
  • NEXT ARTICLE ›
Conferences |5 August 2003

Pathogenesis and Treatment of HIV-Associated Renal Diseases: Lessons from Clinical and Animal Studies, Molecular Pathologic Correlations, and Genetic Investigations Free

Paul L. Kimmel, MD; Laura Barisoni, MD; Jeffrey B. Kopp, MD

Paul L. Kimmel, MD
From George Washington University Medical Center, Washington, DC, and National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.

Laura Barisoni, MD
From George Washington University Medical Center, Washington, DC, and National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.

Jeffrey B. Kopp, MD
From George Washington University Medical Center, Washington, DC, and National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.

Article, Author, and Disclosure Information
Author, Article, and Disclosure Information
  • From George Washington University Medical Center, Washington, DC, and National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.

    Grant Support: Dr. Kimmel was supported by grant RO1-DK-40811 from the National Institute of Diabetes and Digestive and Kidney Diseases.

    Potential Financial Conflicts of Interest: None disclosed.

    Requests for Single Reprints: Paul L. Kimmel, MD, Division of Renal Diseases and Hypertension, Department of Medicine, George Washington University Medical Center, 2150 Pennsylvania Avenue NW, Washington, DC 20037.

    An edited summary of a Clinical Staff Conference Grand Rounds held on 27 June 2001 at the National Institutes of Health, Bethesda, Maryland.

    Authors who wish to cite a section of the conference and specifically indicate its author may use this example for the form of the reference:

    Barisoni L. Pathologic features of HIV-associated nephropathy. In: Kimmel PL, moderator. Pathogenesis and treatment of HIV-associated renal diseases: lessons from clinical and animal studies, molecular pathologic correlations, and genetic investigations.

    Current Author Addresses: Dr. Kimmel: Division of Renal Diseases and Hypertension, Department of Medicine, George Washington University Medical Center, 2150 Pennsylvania Avenue NW, Washington, DC 20037.

    Drs. Barisoni and Kopp: Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Building 10, 3N116, Bethesda, MD 20892.

×
  • ‹ PREV ARTICLE
  • This Issue
  • NEXT ARTICLE ›
Jump To
  • Full Article
  • FULL ARTICLE
  • FULL ARTICLE
    • Abstract
    • Clinical Aspects of Renal Syndromes in HIV-Infected Patients
    • HIV-Associated Thrombotic Microangiopathy
    • HIV-Associated Immune-Mediated Glomerulonephritides
    • Classic HIV-Associated Nephropathy
    • Approach to the HIV-Infected Patient with Chronic Kidney Disease
    • Pathologic Features of HIV-Associated Nephropathy
    • Epithelial Cell Phenotype in HIV-Associated Nephropathy
    • Epithelial Cells Are a Target of HIV Infection
    • Mechanisms of HIV-Associated Renal Injury
    • Host Genetic Variation and the Development of HIV-Associated Nephropathy
    • Conclusions
      1. References
  • Figures
  • Tables
  • Supplements
  • Audio/Video
  • Summary for Patients
  • Clinical Slide Sets
  • CME / MOC
  • Comments
  • Twitter Link
  • Facebook Link
  • Email Link
More
  • LinkedIn Link

Abstract

HIV infection is associated with several renal syndromes, including acute renal failure. Chronic renal failure directly linked to HIV infection includes thrombotic microangiopathic renal diseases, immune-mediated glomerulonephritides, and HIV-associated nephropathy. A renal biopsy may be necessary for diagnosis. The development of HIV-associated nephropathy has been definitively linked to renal cellular infection, but the disease affects only a minority of patients, typically men of African descent. Therefore, factors determining disease expression in infected patients must now be emphasized.

The pathogenic mechanisms involved in HIV-associated renal disease remain obscure. Genetic factors, as well as renal cellular responses, mediated by HIV proteins (including an immune-activated microenvironment) capable of presenting antigen in susceptible hosts probably explain most cases. HIV-associated nephropathy has a characteristic pathologic phenotype, including glomerular, tubular, and interstitial changes, and ultrastructural findings. Infection of the glomerular epithelial cell, or podocyte, and consequent structural and biochemical changes may be pivotal in pathogenesis. The HIV-1 transgenic mouse is an important model for understanding disease pathogenesis, particularly the role of HIV proteins in mediating renal tissue injury.

Rigorously controlled randomized trials have not evaluated treatment, but corticosteroids and angiotensin-converting enzyme inhibitors have been used. Highly active antiretroviral therapy seems to have decreased the incidence of end-stage renal disease related to HIV infection and, in case reports, to have improved renal functional and pathologic outcomes of HIV-associated nephropathy. Outcomes in patients undergoing hemodialysis and peritoneal dialysis have improved, and current research focuses on renal transplantation for treatment of HIV-infected patients.

Dr. Paul L. Kimmel (Division of Hematologic, Kidney and Urologic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health [NIH], Bethesda, Maryland, and George Washington University Medical Center, Washington, DC): Renal disease associated with AIDS was first reported in 1984 and 1985 in New York, New York, and Miami, Florida (1-3). Rao and colleagues from Brooklyn, New York, identified a single renal disease, focal segmental glomerulosclerosis, associated with AIDS (1), while other reports from Miami and Manhattan emphasized a spectrum of glomerular abnormalities and various renal syndromes seen in patients with AIDS (2, 3).
A variety of renal syndromes can complicate the course of HIV infection (4). Clinical strategies involve diagnosing the type of renal disease and instituting appropriate therapy. Research needs involve understanding the pathogenesis of individual renal diseases that complicate HIV infection, understanding the relationship of these diseases to infection and its treatment, and devising treatments for patients with chronic kidney disease.

Clinical Aspects of Renal Syndromes in HIV-Infected Patients

Acute Renal Failure

Although common causes of acute renal failure, as in uninfected hospitalized patients, are prerenal azotemia and acute tubular necrosis (5, 6), recent studies highlight an increased incidence of HIV-associated thrombotic microangiopathies and rhabdomyolysis (7-9); the latter may stem from statin use in patients with complications of antiretroviral therapy (10-14). Opportunistic infections complicating the viral illness, such as tuberculosis, cytomegalovirus infection, and fungal infections, and complications, such as lymphoma and Kaposi sarcoma, are associated with structural anatomic abnormalities, renal insufficiency, and acute renal failure (6, 8). Chronic kidney disease, such as thrombotic thrombocytopenic purpura, associated with HIV infection, can also mimic acute renal failure (4, 6, 15). Drugs used to treat superinfections associated with HIV infection (for example, antibiotics, antifungals, and antivirals) and antiretroviral drugs to treat HIV infection (for example, indinavir and ritonavir) (16) are associated with the development of interstitial nephritis and nephrotoxicity. Antibiotics commonly cause acute interstitial nephritis, while aminoglycosides, amphotericin, and foscarnet cause acute tubular necrosis. The nucleoside phosphonate analogues adefovir and cidofovir cause proximal renal tubular injury (16). Abacavir (17) and tenofovir (18, 19) are implicated in the development of tubular injury and renal failure. Sulfadiazine, acyclovir, and indinavir cause crystalluria and, occasionally, intrarenal obstruction (20). Indinavir is associated with several nephrologic syndromes, such as dysuria, acute and chronic interstitial nephritis (including tubular atrophy and interstitial fibrosis), and nephrolithiasis; nelfinavir has been linked to the development of nephrolithiasis (10, 16, 21-23). Leukocyturia is associated with progressive renal disease in patients treated with indinavir (22, 24).

Chronic Renal Disease: End-Stage Renal Disease

Currently, HIV-infected patients make up approximately 1% to 2% of the population with end-stage renal disease (25-27) (Figure 1). The incidence geographically reflects the national distribution of AIDS and HIV infection (25, 26). The prevalence of HIV infection in the dialysis program is probably higher because of confidentiality issues and the lack of biopsies in most patients. During the late 1980s, the number of HIV-infected patients in the dialysis program was low but had tripled from 1985 to 1988 (25, 27) (Figure 1). However, subsets of the population, such as young black men, were at particularly high risk for developing nephropathy (28, 29). The relative risk for end-stage renal disease from AIDS or an AIDS-defining diagnosis from 1995 to 1999 is 0.39 for women compared with men (Eggers PW. Personal communication). Risk between men and women does not vary by race or ethnicity, but black patients had a relative risk of 51.1 for developing end-stage renal disease from AIDS or an AIDS-defining diagnosis compared with white patients. Although early work suggested a rapidly increasing number of HIV-infected patients (28), the number and proportion of patients undergoing dialysis who had renal disease attributed to HIV infection have stabilized or are decreasing (25-27) (Figure 1). Between 1995 and 1999, the number of new patients with HIV infection in the U.S. hemodialysis program ranged from 1131 to 1187 and did not rise proportionately with the increase in HIV infection or the U.S. dialysis population (26).
Figure 1.

Percentage of HIV-infected patients receiving hemodialysis in the U.S. hemodialysis program

Chronic Renal Failure

The prevalence of renal disease related to HIV infection is unknown, rendering epidemiologic assessments problematic (29). The designation of chronic kidney disease in HIV-infected patients depends on the screening techniques used (30). Data before (30, 31) and after (32) the introduction of highly active antiretroviral therapy suggest a prevalence of abnormal proteinuria of about one third, using various criteria. A European autopsy study of HIV-infected patients, most of whom had developed AIDS, showed proteinuria in 18%, nephropathy in 36%, and renal pathology in 43% (31). Less than 10% of a cohort of HIV-infected women had proteinuria or renal insufficiency at baseline, but 14% developed kidney disease during a mean 21-month follow-up (33). In a large study of HIV-infected women, viral load and stage of infection were associated with proteinuria and progressive nephropathy but presence and type of antiretroviral therapy were not (32).
Three types of chronic kidney disease are directly caused by HIV infection: HIV-associated thrombotic microangiopathies, HIV immune-mediated renal diseases, and classic HIV-associated nephropathy (4, 27). Because of improved understanding of the HIV life cycle, advances in molecular biological tissue evaluation, and the development of relevant animal models, stronger pathogenic inferences can be made about HIV-associated nephropathies compared with other renal diseases. Elucidating the pathogenesis of HIV-associated renal diseases also permits better understanding of pathogenic mechanisms underlying more common renal diseases.

HIV-Associated Thrombotic Microangiopathy

The thrombotic microangiopathies, hemolytic uremic syndrome and thrombotic thrombocytopenic purpura, are thought to occur because of endothelial cell dysfunction partially mediated by HIV proteins (4, 15, 34-36). Renal cellular apoptosis (4, 15, 34, 37), as well as inhibition of von Willebrand factorcleaving protease (38), may play key pathogenic roles. The disease spectrum is characterized by a pentad of findings with variable expression: fever, neurologic dysfunction, thrombocytopenia, microangiopathic hemolytic anemia, and renal insufficiency with hematuria. High-level proteinuria is uncommon, which helps differentiate these syndromes from immune-mediated diseases and HIV-associated nephropathy (4). However, nephrotic-range proteinuria does occur (39-41), perhaps because of the coexistence of two diseases (41). Although spontaneous remissions occur (40), the renal disease often resists treatment. Treatment with glucocorticoids (41, 42), plasma and immunoglobulin infusions, plasmapheresis, antiplatelet drugs, vincristine, and splenectomy has variable success (15, 27), but lack of controlled trials precludes evidence-based recommendations.

HIV-Associated Immune-Mediated Glomerulonephritides

Autopsy and biopsy series in HIV-infected patients with renal disease have established a prevalence of proliferative glomerulonephritis of 10% to 80% (42-49). Immune complex glomerulonephritis associated with HIV infection has several different histologic presentations (43, 49), including proliferative, lupus-like, and mixed proliferative or sclerotic forms (43). Other types of glomerulonephritis, such as membranoproliferative glomerulonephritis, membranous nephropathy, fibrillary and immunotactoid glomerulonephritis, and postinfectious glomerulonephritis, also occur in HIV-infected patients (43, 45, 46, 49-52). The renal disease, however, may not be intimately associated with HIV infection. Rather, it may be a consequence of coexistent infection, such as renal disease related to hepatitis C or B (49, 53-55), a response to infection in patients with disordered humoral immunity (49, 56), or a coincidental finding (49). A renal biopsy with immunochemical and molecular biological analyses is necessary to make a precise etiologic diagnosis, but this is usually not possible in clinical practice. By using classic research techniques, we showed that the immune response to HIV infection could culminate in specific HIV immune-mediated glomerulonephritis (57).
IgA nephropathy occurs in HIV-infected patients (4, 49, 58, 59). Its incidence and prevalence are unknown. In an autopsy study, 7.75% of persons with AIDS had diffuse mesangial IgA deposits (60). IgA nephropathy in HIV infection seems to be relatively common in men of European descent but uncommon in people of African descent (27, 49, 60), as in uninfected populations (61). We showed that IgA nephropathy in two patients was the result of an autoimmune reaction to HIV peptides (59). HIV-associated IgA nephropathy is generally indolent, characterized by proteinuria, hematuria, and mild renal insufficiency.
European and Asian case series of patients with HIV infection and renal disease who underwent biopsies or autopsies show that patients of European descent typically have glomerulonephritis, while patients of African descent in the same centers usually have HIV-associated nephropathy (31, 43, 45-49). These disparities and the clustering of renal disease in families of patients with HIV infection and end-stage renal disease (62) suggest a genetic component for developing both HIV-associated immune-mediated renal diseases and HIV-associated nephropathy.
Remarkable responses have been reported in patients with immune-mediated renal diseases treated with angiotensin-converting enzyme (ACE) inhibitors, glucocorticoids, or antiretroviral therapy (51, 63-65), but properly designed randomized, controlled trials have not assessed such therapies.

Classic HIV-Associated Nephropathy

Although some researchers suggest that HIV-associated nephropathy comprises a spectrum of mesangial diseases and matrix production disorders (66), variants of focal segmental glomerulosclerosis, including collapsing glomerulopathy, were reported in most HIV-infected patients with renal disease who underwent renal biopsy (4, 27, 67, 68). HIV-associated nephropathy is characterized by large, echogenic kidneys on ultrasonography, nephrotic-range proteinuria, and renal insufficiency. Although it has been argued that HIV-associated nephropathy is a late complication (67, 69), it can clearly occur at any stage of HIV infection and is occasionally the presenting manifestation of infection (70-72). The pathologic findings are pathognomonic (66-68, 73, 74). Although clinical findings are suggestive, a biopsy is necessary for diagnosis. Before the introduction of highly active antiretroviral therapy in 1996, HIV-associated nephropathy was typified by an extremely rapid progression that was thought to be inexorable.

Pathogenic Considerations

The pathogenesis of HIV-associated nephropathy is unknown, but three lines of evidence definitively link the disease to viral infection: 1) the finding of HIV-associated nephropathy in infected infants of HIV-infected mothers [75]; 2) the reproduction of the disease in HIV-1 transgenic mice, rats, and simian models of retroviral infection [15, 76-79]; and 3) reports of reversal of renal histologic and laboratory abnormalities in a small set of patients with biopsy-proven HIV-associated nephropathy after highly active antiretroviral therapy (70, 72).
We showed the ubiquitous presence of HIV DNA in renal tissue of HIV-infected patients (44), but only recently has human renal viral infection been demonstrated by the localization of HIV-1 messenger RNA in renal tissue, specifically glomerular and tubular epithelial cells (72, 80-82). However, proteinuria is present in less than half of HIV-infected patients (30-33), and advanced stages of chronic kidney disease are an uncommon complication of HIV infection (4, 27, 66, 67). Therefore, factors other than simple infection of renal cells or the infiltration of infected immune cells in renal tissue probably mediate the expression of nephropathy (4, 44). Large-scale clinical epidemiologic and pathologic studies of the relationship of renal HIV infection to the expression of disease, with the proper positive and negative controls, remain to be performed.
Cytokines and growth factors, produced by infiltrating immune or renal cells, undoubtedly play roles in mediating disease pathogenesis in susceptible hosts through effects on renal cells or the viral life cycle. The presence of an immune cell infiltrate in the renal tissue of patients with HIV-associated nephropathy remains unexplained, but clinicopathologic data implicate the macrophage in the pathogenesis of HIV-associated nephropathy (83). Chemokines mediate infiltration of tissue by monocytes, macrophages, lymphocytes, neutrophils, and eosinophils and have been implicated in nephropathogenesis (84). Certain chemokine receptors function as second receptors for the engagement of HIV virions and the cell membrane (85). Mutations in chemokine receptor proteins are associated with resistance to HIV infection and improved prognosis (86). Chemokine receptor RNA has been detected in renal tissue (84, 87, 88), but detecting chemokine receptors in HIV-associated nephropathy tissue is limited to infiltrating immune cells (89). We investigated the relationship of tissue transforming growth factor- (90) and chemokines (91) to the presence of nephropathy by comparing biopsy specimens from patients with HIV-associated nephropathy, HIV-associated glomerulonephritis, and idiopathic focal glomerulosclerosis without HIV infection, with appropriate controls. Chemokine levels were increased in renal tissue from patients with HIV infection regardless of the presence of renal disease (91). This finding suggests that chemokines might help prevent productive infection of renal cells by interacting with renal chemokine receptors, thereby decreasing the number of renal cells infected and the subsequent expression of nephropathy. Tissue proteins associated with antigen presentation and response to infection, including MHC class II proteins, interferon-, and interferon- receptor protein, were specifically associated with HIV-associated nephropathy, suggesting that genetic susceptibility, the host response, and a microenvironment characterized by immune activation are critical to nephropathogenesis (Figure 2). The finding of high levels of interferon- is consistent with the pathologic feature of tubuloreticular inclusions (4, 68, 73, 74, 91). Human (92) and animal (93) studies suggest that apoptosis, perhaps mediated by HIV proteins, plays an important role in nephropathogenesis. A complex interrelationship probably exists among renal infection, effects on renal cell matrix biology, cytokine, growth factor, and chemokine responses, mediated by host factors (including genetic susceptibility and socioeconomic status) leading to the development of HIV-associated nephropathy.
Figure 2.

Interferon- protein expression in renal tissue compartmentsPP

Treatment of HIV-Associated Nephropathy

No rigorously controlled randomized trials have evaluated treatment of HIV-associated nephropathy (27, 94). Glucocorticoid therapy produced impressive decreases in urinary protein excretion and improved renal function (95), but treatment before the introduction of highly active antiretroviral therapy was associated with a high prevalence of serious complications (94-97). More recent studies suggest that steroid treatment is associated with improved renal functional outcomes and less morbidity, perhaps secondary to concomitant highly active antiretroviral therapy (96-98). Two studies completed before the introduction of highly active antiretroviral therapies suggest that ACE inhibitors have clinically significant effects on renal survival (99, 100). This effect was confirmed in the HIV-1 transgenic mouse (101). The mechanism of action of these drugs is unknown. Steroids may decrease the associated component of interstitial inflammation (41, 94), while ACE inhibitors may affect interstitial immune cellular function and the generation of tissue cytokines (4, 94, 99).
Antiretroviral drug therapy has been associated with beneficial effects on renal functional status, morbidity, and mortality (4, 27, 94, 102-104). In patients treated with captopril, use of antiretrovirals was independently associated with improved renal survival (99). Two dramatic case reports suggest that treating patients with HIV-associated nephropathy with highly active antiretroviral therapy may result in remission of both renal pathologic and functional abnormalities (70, 72), although the kidney may remain a reservoir of infection (72, 81, 82). Outcomes of HIV-infected patients treated with hemodialysis and peritoneal dialysis have improved and the incidence of HIV infection in the dialysis program seems to have decreased concomitantly with the introduction in 1996 of highly active antiretroviral therapy (25-27, 105, 106) (Figure 1). Although the immunosuppression of HIV-infected patients is a concern, the prospect of transplantation for carefully selected HIV-infected patients is exciting but controversial (27, 107-111). Some of the immunosuppressive medications used in clinical transplantation may have antiretroviral effects (27, 109). Successful transplantation in HIV-infected patients who have received highly active antiretroviral therapy and have undetectable viral loads has been reported in abstract form, and a multicenter study is in progress (27, 108). Murphy and colleagues transplanted kidneys in 23 patients who were receiving antiretroviral therapy, had CD4 cell counts greater than 0.200 109 cells/L, and had undetectable viral loads; the graft survival rate was 87% (27, 108).

Approach to the HIV-Infected Patient with Chronic Kidney Disease

We believe that HIV-infected patients with chronic kidney disease should be assessed by using standard clinical tools. The absence of nephrotic-range proteinuria suggests a diagnosis other than HIV-associated nephropathy or glomeulonephritis. The peripheral smear should be examined in patients with acute or chronic renal disease who have thrombocytopenia or hemolysis. A renal biopsy is necessary to diagnose HIV-associated nephropathy. This may be a clinically significant decision for patients in whom highly active retroviral therapy would otherwise be deferred (112) since antiretroviral therapy can improve outcomes, but renal diseases unrelated to HIV infection would not be expected to respond (4, 27, 44, 113). Although this recommendation is not substantiated by evidence from clinical trials, patients with chronic kidney disease associated with HIV infection should be treated with highly active antiretroviral therapy unless it is contraindicated. A good rationale exists for ACE inhibitors for patients who do not have a dramatic response to such therapy, although the effects of such combinations have not been evaluated prospectively. In selected patients whose viral infection is controlled, the addition of glucocorticoids may improve renal function. Further study is necessary to evaluate the results of combinations of antiretroviral therapy, drugs that interrupt the reninangiotensin axis, and steroids in patients with HIV-associated renal diseases. Renal transplantation is an option for selected patients in controlled trials.

Pathologic Features of HIV-Associated Nephropathy

Dr. Laura Barisoni (Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, and The Johns Hopkins University, Baltimore, Maryland): The appropriate classification of focal segmental glomerulosclerosis is controversial and evolving. Collapsing glomerulopathy represents a subtype of focal segmental glomerulosclerosis, distinguished by one or more glomeruli manifesting segmental or global collapse and podocyte hypertrophy or hyperplasia (114-117). A common associated feature is severe tubular injury and interstitial inflammatory infiltration out of proportion to the glomerular disease. Collapsing glomerulopathy may be associated with HIV-1 infection, in which case it is termed HIV-associated nephropathy, or it may occur without known viral infection. Although idiopathic collapsing glomerulopathy and HIV-associated nephropathy are similar, HIV-associated nephropathy can be distinguished by the presence of tubular microcysts and glomerular endothelial tubuloreticular inclusions (however, these are not always present). Both forms of collapsing glomerulopathy are believed to share common pathogenic mechanisms related to dysregulation of podocyte phenotype (118, 119).
Like collapsing glomerulopathy, HIV-associated nephropathy is characterized by wrinkling and folding of the glomerular basement membranes (Figure 3, part A). The segmental or global collapse of the glomerular basement membrane is associated with increases in the Bowman space. Often this space is partially or globally occupied by large podocytes, with pale cytoplasm containing protein-reabsorption droplets. These cells are arranged in layers around the collapsed areas, forming pseudocrescents. Glomerular damage is associated with tubular atrophy and flattening and regeneration of the tubular epithelium (Figure 3, part B). Interstitial inflammation and fibrosis are generally severe.
Figure 3.

Histopathologic characteristics of HIV-associated nephropathy in humans and transgenic mice.A.B.C.PasterisksD and E.DEDEF and G.FGbrown

In many glomerular diseases, proteinuria is associated with podocyte foot process effacement and reorganization and with condensation of the actin cytoskeleton; the latter manifests as dense intracytoplasmic structures lying adjacent to the glomerular basement membrane. HIV-associated nephropathy podocyte structure is different (Figure 3, part C). Podocytes lose their foot and primary cytoplasmic processes, so the cell body rests directly on the glomerular basement membrane. The actin cytoskeleton is essentially absent. These features resemble those of immature podocytes in the developing glomerulus, supporting the hypothesis that cellular dedifferentiation has occurred. In some cases, podocytes detach and new extracellular matrix deposits fill the resulting space (118).

Epithelial Cell Phenotype in HIV-Associated Nephropathy

In all forms of focal glomerulosclerosis and in HIV-associated nephropathy, expression of maturity markers, such as synaptopodin, glomerular epithelial protein 1, podocalyxin, C3b receptor, and common acute lymphoblastic leukemia antigen, is lost in the areas of sclerosis or collapse (Figure 3, parts D and E) (118). In other forms of focal glomerulosclerosis, this phenomenon may result from parietal epithelial cell migration from the Bowman capsule. In HIV-associated nephropathy, this phenomenon may reflect dedifferentiation of podocytes overlying areas of collapse. The loss of actin-based cytoskeleton observed on ultrastructural analysis is reflected by the absence of synaptopodin staining, which also occurs in podocytes overlying noncollapsed glomeruli; this finding suggests that cellular phenotypic alteration precedes glomerular injury. Moreover, podocalyxin, normally expressed in both podocytes and endothelial cells, is lost exclusively in podocytes, suggesting that HIV-associated nephropathy is a selective podocyte disease.
In HIV-associated nephropathy, the podocyte phenotype is not only dedifferentiated but also dysregulated, reflected by loss of expression of Wilm tumor protein 1, a podocyte marker present at all stages of glomerular development (118). In idiopathic collapsing glomerulopathy, dysregulated podocytes may express proteins that are more typically expressed by other cells, such as macrophages, in a process called transdifferentiation (120). Unlike all other diseases characterized by podocyte injury, dysregulated podocytes in patients with HIV-associated nephropathy or idiopathic collapsing glomerulopathy proliferate and also undergo apoptosis (120, 121). The reentry into the cell cycle coincides with the loss of expression of cyclin D1 and cyclin-dependent kinase inhibitors, p27 and p57, together with reexpression of cyclin A and Ki-67 and the de novo expression of p21 (122).
Podocytes have several functions (123). The podocyte slit diaphragm contributes to the glomerular filtration barrier, limiting urinary albumin and large-molecular-weight protein excretion. Podocytes participate in laying down and remodeling the glomerular basement membrane. Podocytes may have structural functions within the glomerulus, maintaining capillary loop structure against both the ballooning force of hydrostatic pressure and the contractile force of mesangial cells. It is not surprising that dedifferentiated podocytes may fail to perform one or more of these functions. Loss of the slit diaphragms (foot process effacement) is associated with proteinuria. The dedifferentiated podocyte may contribute to glomerular collapse by shifting synthesis from collagen IV 3, 4, and 5 chains, typical of the adult glomerular basement membrane, to those typical of its fetal composition (collagen IV 1 and 2 chains), which are present in the glomerular basement membrane in HIV-associated nephropathy. Finally, the pressure of the expanding podocyte cell mass that makes up a pseudocrescent may contribute to capillary loop collapse (Figure 4).
Figure 4.

Model for glomerular and tubular cell injury induced by HIV-1

Epithelial Cells Are a Target of HIV Infection

The HIV-1 transgenic mouse model of HIV nephropathy, developed at the NIH, directly linked the expression of HIV-1 proteins to altered cellular phenotype (124). HIV-1 transgenic mice develop a renal disease similar to HIV-associated nephropathy, including focal segmental glomerulosclerosis with glomerular collapse, severe tubulointerstitial damage, and tubular microcysts (76). Tubular epithelial cells lose the expression of proteins, such as Na+, K+adenosine triphosphatase, and adducin (119) (Figure 3, parts F and G). Two pieces of evidence link HIV gene expression and renal parenchymal changes. In cross-transplant experiments between wild-type and HIV-1 transgenic mice, nephropathy developed only in kidneys transplanted from transgenic into wild-type mice (93). Second, transgene expression was detected in both podocytes and tubular epithelial cells before structural alterations occurred. In renal epithelium, the detection of the transgene is followed by high apoptotic and proliferative indices together with dysregulation of the phenotype, indicating a temporal correlation between HIV-1 expression and nephropathy (121).
HIV-1 gene expression in podocytes and tubular epithelium of multiple nephron segments has been demonstrated in human biopsy specimens (72, 81), suggesting a role of HIV-1 infection in initiating pathogenesis, although the mechanism underlying cellular damage is unknown. To support this hypothesis, recent studies in podocytes derived from HIV-1 transgenic mice indicate a direct effect of HIV-1 gene products on the cell cycle, leading to cellular proliferation (125).

Mechanisms of HIV-Associated Renal Injury

Dr. Jeffrey B. Kopp (Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, NIH): The mechanisms by which lentiviruses induce characteristic glomerular and tubular injury are not well understood, but several important clues to pathogenesis have emerged over the past decade.
Opportunistic renal infections might trigger focal segmental glomerulosclerosis. Although it was suggested that Mycoplasma fermentans might contribute, few recent data support that hypothesis (126). We showed that the monkey polyomavirus simian virus 40 is recovered more frequently from urinary cells of patients with focal glomerulosclerosis, including idiopathic, collapsing, and HIV-associated variants, compared with patients with other kidney diseases or healthy volunteers (127). These data are insufficient, however, to establish a causative link between simian virus 40 infection and HIV-associated nephropathy.
HIV-1 probably infects lymphocytes and macrophages that enter the kidney, which might release inflammatory lymphokines or cytokines and cause renal injury. Biopsy specimens from patients with HIV-associated nephropathy have a striking increase in renal transforming growth factor-producing cells compared with specimens from patients with other forms of focal segmental glomerulosclerosis or other inflammatory glomerular diseases (90, 128). Neither study conclusively identified the cells responsible for producing transforming growth factor-.
Increasing evidence suggests that HIV-1 may infect renal parenchymal cells, producing cytopathic effects such as proliferation or apoptosis. In vitro experiments demonstrated low-level productive infection of cultured tubular epithelial cells (87, 129). Some investigators have reported infection of cultured mesangial cells (130), while others have not (131). The role of the chemokine receptor GPR1 may be critical (132). In vitro infection of human podocytes, however, has not yet been described. Localization of HIV-1 protein and RNA to renal parenchymal cells has been controversial. Both HIV-1 protein and nucleic acid were found in podocytes and tubular epithelium (44, 133). Recently, Klotman and colleagues (72, 81, 82) developed sensitive in situ hybridization techniques and localized viral RNA and newly retrotranscribed proviral DNA to podocytes and tubular epithelial cells (72, 81). Future work may delineate how HIV-1 infection leads to cellular abnormalities such as proliferation (podocytes) or atrophy and death (tubular epithelial cells).
HIV-1 proteins may directly injure renal parenchymal cells. In humans infected with HIV-1, overt immunodeficiency is not required for development of focal glomerulosclerosis, suggesting that some lentiviral gene product might be responsible for nephropathogenesis. Experiments using HIV-1 transgenic mice show that particular HIV-1 accessory proteins can induce focal segmental glomerulosclerosis and interstitial nephritis (124, 134-136) (Table). These features include focal and segmental collapse and solidification of the glomerular capillary tuft, podocyte hyperplasia (but not glomerular endothelial tubuloreticular inclusions), microcystic tubular dilatation, tubular atrophy, mononuclear interstitial cell infiltration, proteinuria, and progressive renal dysfunction. These transgenic mice do not produce virions (since the gag and pol genes are lacking from the transgenes), demonstrating that replicating virus is not required for the induction of murine nephropathy. Two lines of evidence suggest that local renal HIV-1 protein production is critical: Transgenic lines that do not express the transgene in the kidney but express it in other tissues do not develop renal disease (124), and nephropathy follows the transgenic kidney in renal transplant experiments involving transgenic and wild-type mice (93).

Table. HIV-1 Transgenic Mice with Renal Disease

Table. HIV-1 Transgenic Mice with Renal Disease
A provisional summary of these data suggests that the viral regulatory or accessory proteins Tat plus viral protein R (Vpr), or Vpr acting alone, may induce focal glomerulosclerosis, and Nef (negative factor for viral replication) may contribute to interstitial nephritis. These viral proteins have complex effects on host cell function. Dissecting the mechanisms of renal injury induced by these proteins is an area for future research. Tat is a transactivating protein that increases viral RNA production. Vpr has many effects on host cells, including G2 cell cycle arrest, regulation of apoptosis, and cytokine production, and acts as a transcriptional coactivator or corepressor, depending on the genetic context. Nef downregulates CD4 expression. In summary, in mice, particular viral regulatory or accessory proteins induce many characteristic functional and histologic changes of HIV-associated nephropathy.
Viral genetic variation might contribute to the epidemiology of HIV-associated nephropathy, explaining why only some patients develop renal disease. Partly because of the relatively high error rate of HIV-1 reverse transcriptase, the HIV-1 genome is highly plastic and many viral quasi-species exist. The env (envelope) gene encodes the transmembrane glycoprotein (gp) 41 and the associated gp120. gp120 first binds CD4, inducing a conformational change in gp120 that facilitates its binding to one of several co-receptor molecules, which function as chemokine receptors in the host. CD4 independent cell infection has also been described. The receptors responsible for viral entry into renal parenchymal cells have not been well characterized. CD4 has not been convincingly demonstrated on any renal parenchymal cell in vivo, although RNA has been reported in cultured tubular epithelial cells. Mesangial cell infection may be dependent on GPR1 (132). Particular viral variants may have mutations in gp120 that facilitate entry into renal cells or have mutations in regulatory or accessory proteins, such as Vpr or Nef, with particular toxicity for renal cells, but few data address this issue.

Host Genetic Variation and the Development of HIV-Associated Nephropathy

People of African descent with HIV-1 infection are at a markedly increased risk for focal segmental glomerulosclerosis, with an at least 18-fold increased risk compared with people of European descent (137). Since a similar predilection is seen in the United States, Europe, and South America, cultural factors seem an unlikely explanation. Instead, one or more host genetic loci probably contribute to risk, with particular risk alleles more common in populations of African descent. Theoretically, these alleles might contribute to HIV-1 entry into renal parenchymal cells, potentiate toxicity of viral accessory proteins in renal cells, or heighten a fibrotic response to viral-initiated renal injury.
A genetic mutation that contributes to HIV-associated nephropathy might be unique for this syndrome or extend to idiopathic focal segmental glomerulosclerosis or other forms of glomerular injury. While there is no evidence that the first possibility is correct, the relative rarity of HIV-1 infection (<0.2% of the U.S. population is infected) makes it difficult to estimate the risk for HIV-associated nephropathy among different kindreds. However, probands with HIV infection and renal disease have an increased number of first- and second-degree relatives with renal disease (not limited to focal glomerulosclerosis) compared with ethnically matched patients with HIV-1 infection without kidney disease (62). These data tend to support the second or third possibility outlined. At present, it seems that HIV-associated nephropathy probably has both genetic and environmental components.
We have initiated ongoing studies comparing genetic polymorphisms among African Americans with HIV-associated nephropathy, idiopathic focal segmental glomerulosclerosis, and HIV-1 infection for at least 8 years but without renal disease (a hypernormal control group, in that these individuals have been challenged with a virus known to induce focal glomerulosclerosis but have not developed this syndrome), African-American blood donors, and European-American patients with idiopathic focal segmental glomerulosclerosis and blood donors. We have performed genotyping in these individuals for polymorphisms in various candidate genes, including those for chemokine receptors, chemokines, and members of the reninangiotensin-transforming growth factor- system. To date, preliminary studies demonstrate that the only gene that differs between African-American patients with HIV-associated nephropathy and African-American controls is the gene encoding ACE (138). Patients homozygous for an Alu insertion in intron 16 of ACE are at an increased risk for focal segmental glomerulosclerosis; this is true for both African Americans with HIV-associated focal segmental glomerulosclerosis and those with idiopathic focal segmental glomerulosclerosis. In European Americans, the ACE polymorphism was not significantly associated with focal segmental glomerulosclerosis.
Angiotensin-converting enzyme polymorphisms have been associated with the incidence or rate of progression of various glomerular diseases, including diabetes (139), IgA nephropathy (140), and idiopathic focal segmental glomerulosclerosis (141, 142) in Asian patients, but all these studies suggest that patients homozygous for the intron 16 deletion allele are more susceptible. Of interest, these studies have included few African Americans. Unlike other populations, in African Americans, there is no correlation between intron 16 polymorphism and serum ACE level (143). We interpret these data to suggest that, in African Americans, the intron 16 polymorphism is in linkage disequilibrium with one or more mutations that contribute to focal segmental glomerulosclerosis risk.

Conclusions

Much has been learned about the pathogenesis and treatment of HIV-associated renal diseases because of the development of animal models and the molecular evaluation of clinical samples. Although the pathogenesis of HIV-associated nephropathy is clearly linked to the viral illness, over the next decade we must determine how infection results in the development of disease. HIV peptides rather than infection may be more important in nephropathogenesis. We must determine why some patients are susceptible to disease development and others are not. Genetic factors, the host response, and effects of HIV peptides on podocytes, on renal cellular apoptosis, and on the ability to present antigen may be critical to pathogenesis. Although highly active antiretroviral therapy will play an important role in preventing and treating HIV-associated nephropathy, well-designed and -controlled clinical trials are necessary to determine the roles of therapy with glucocorticoids and ACE inhibitors. Knowledge about the treatment of HIV-infected patients with renal transplantation and proper treatment of other HIV-associated renal diseases is rudimentary.

References

  1. Rao
    TK
    ,  
    Filippone
    EJ
    ,  
    Nicastri
    AD
    ,  
    Landesman
    SH
    ,  
    Frank
    E
    ,  
    Chen
    CK
    ,  
    .  
    Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome
    N Engl J Med
    1984
    310
    669
    73
     PubMed
    CrossRef
     PubMed
  2. Pardo
    V
    ,  
    Aldana
    M
    ,  
    Colton
    RM
    ,  
    Fischl
    MA
    ,  
    Jaffe
    D
    ,  
    Moskowitz
    L
    ,  
    .  
    Glomerular lesions in the acquired immunodeficiency syndrome
    Ann Intern Med
    1984
    101
    429
    34
    CrossRef
     PubMed
  3. Gardenswartz
    MH
    ,  
    Lerner
    CW
    ,  
    Seligson
    GR
    ,  
    Zabetakis
    PM
    ,  
    Rotterdam
    H
    ,  
    Tapper
    ML
    ,  
    .  
    Renal disease in patients with AIDS: a clinicopathologic study
    Clin Nephrol
    1984
    21
    197
    204
     PubMed
     PubMed
  4. Kimmel
    PL
    .  
    The nephropathies of HIV infection: pathogenesis and treatment
    Curr Opin Nephrol Hypertens
    2000
    9
    117
    22
     PubMed
    CrossRef
     PubMed
  5. Rao
    TK
    ,  
    Friedman
    EA
    ,  
    Nicastri
    AD
    .  
    The types of renal disease in the acquired immunodeficiency syndrome
    N Engl J Med
    1987
    316
    1062
    8
     PubMed
    CrossRef
     PubMed
  6. Rao
    TK
    .  
    Acute renal failure syndromes in human immunodeficiency virus infection
    Semin Nephrol
    1998
    18
    378
    95
     PubMed
     PubMed
  7. Peraldi
    MN
    ,  
    Maslo
    C
    ,  
    Akposso
    K
    ,  
    Mougenot
    B
    ,  
    Rondeau
    E
    ,  
    Sraer
    JD
    .  
    Acute renal failure in the course of HIV infection: a single-institution retrospective study of ninety-two patients anad sixty renal biopsies
    Nephrol Dial Transplant
    1999
    14
    1578
    85
     PubMed
    CrossRef
     PubMed
  8. Perazella
    MA
    .  
    Acute renal failure in HIV-infected patients: a brief review of common causes
    Am J Med Sci
    2000
    319
    385
    91
     PubMed
    CrossRef
     PubMed
  9. Joshi
    MK
    ,  
    Liu
    HH
    .  
    Acute rhabdomyolysis and renal failure in HIV-infected patients: risk factors, presentation, and pathophysiology
    AIDS Patient Care STDS
    2000
    14
    541
    8
     PubMed
    CrossRef
     PubMed
  10. Kopp
    JB
    .  
    Renal dysfunction in HIV-1-infected patients
    Curr Infect Dis Rep
    2002
    4
    449
    460
     PubMed
    CrossRef
     PubMed
  11. Hare
    CB
    ,  
    Vu
    MP
    ,  
    Grunfeld
    C
    ,  
    Lampiris
    HW
    .  
    Simvastatin-nelfinavir interaction implicated in rhabdomyolysis and death
    Clin Infect Dis
    2002
    35
    e111
    2
     PubMed
    CrossRef
     PubMed
  12. Cheng
    CH
    ,  
    Miller
    C
    ,  
    Lowe
    C
    ,  
    Pearson
    VE
    .  
    Rhabdomyolysis due to probable interaction between simvastatin and ritonavir
    Am J Health Syst Pharm
    2002
    59
    728
    30
     PubMed
     PubMed
  13. Castro
    JG
    ,  
    Gutierrez
    L
    .  
    Rhabdomyolysis with acute renal failure probably related to the interaction of atorvastatin and delavirdine [Letter]
    Am J Med
    2002
    112
    505
     PubMed
    CrossRef
     PubMed
  14. Mastroianni
    CM
    ,  
    d'Ettorre
    G
    ,  
    Forcina
    G
    ,  
    Lichtner
    M
    ,  
    Corpolongo
    A
    ,  
    Coletta
    S
    ,  
    .  
    Rhabdomyolysis after cerivastatin-gemfibrozil therapy in an HIV-infected patient with protease inhibitor-related hyperlipidemia [Letter]
    AIDS
    2001
    15
    820
    1
     PubMed
    CrossRef
     PubMed
  15. Alpers
    CE
    .  
    Light at the end of the TUNEL: HIV-associated thrombotic microangiopathy
    Kidney Int
    2003
    63
    385
    96
     PubMed
    CrossRef
     PubMed
  16. Olyaei
    AJ
    ,  
    deMattos
    AM
    ,  
    Bennett
    WM
    .  
    Renal toxicity of protease inhibitors
    Curr Opin Nephrol Hypertens
    2000
    9
    473
    6
     PubMed
    CrossRef
     PubMed
  17. Krishnan
    M
    ,  
    Nair
    R
    ,  
    Haas
    M
    ,  
    Atta
    MG
    .  
    Acute renal failure in an HIV-positive 50-year-old man
    Am J Kidney Dis
    2000
    36
    1075
    8
     PubMed
    CrossRef
     PubMed
  18. Coca
    S
    ,  
    Perazella
    MA
    .  
    Rapid communication: acute renal failure associated with tenofovir: evidence of drug-induced nephrotoxicity
    Am J Med Sci
    2002
    324
    342
    4
     PubMed
    CrossRef
     PubMed
  19. Verhelst
    D
    ,  
    Monge
    M
    ,  
    Meynard
    JL
    ,  
    Fouqueray
    B
    ,  
    Mougenot
    B
    ,  
    Girard
    PM
    ,  
    .  
    Fanconi syndrome and renal failure induced by tenofovir: a first case report
    Am J Kidney Dis
    2002
    40
    1331
    3
     PubMed
    CrossRef
     PubMed
  20. Perazella
    MA
    .  
    Crystal-induced acute renal failure
    Am J Med
    1999
    106
    459
    65
     PubMed
    CrossRef
     PubMed
  21. Kopp
    JB
    ,  
    Miller
    KD
    ,  
    Mican
    JA
    ,  
    Feuerstein
    IM
    ,  
    Vaughan
    E
    ,  
    Baker
    C
    ,  
    .  
    Crystalluria and urinary tract abnormalities associated with indinavir
    Ann Intern Med
    1997
    127
    119
    25
    CrossRef
     PubMed
  22. Reilly
    RF
    ,  
    Tray
    K
    ,  
    Perazella
    MA
    .  
    Indinavir nephropathy revisited: a pattern of insidious renal failure with identifiable risk factors
    Am J Kidney Dis
    2001
    38
    E23
     PubMed
    CrossRef
     PubMed
  23. Engeler
    DS
    ,  
    John
    H
    ,  
    Rentsch
    KM
    ,  
    Ruef
    C
    ,  
    Oertle
    D
    ,  
    Suter
    S
    .  
    Nelfinavir urinary stones
    J Urol
    2002
    167
    1384
    5
     PubMed
    CrossRef
     PubMed
  24. Dieleman
    JP
    ,  
    van Rossum
    AM
    ,  
    Stricker
    BC
    ,  
    Sturkenboom
    MC
    ,  
    de Groot
    R
    ,  
    Telgt
    D
    ,  
    .  
    Persistent leukocyturia and loss of renal function in a prospectively monitored cohort of HIV-infected patients treated with indinavir
    J Acquir Immune Defic Syndr
    2003
    32
    135
    42
     PubMed
    CrossRef
     PubMed
  25. Tokars
    JI
    ,  
    Frank
    M
    ,  
    Alter
    MJ
    ,  
    Arduino
    MJ
    .  
    National surveillance of dialysis-associated diseases in the United States, 2000
    Semin Dial
    2002
    15
    162
    71
     PubMed
    CrossRef
     PubMed
  26. Eggers
    PW
    ,  
    Kimmel
    PL
    .  
    Is there an epidemic of HIV nephropathy in the U.S
    ESRD program? [Abstract] J Am Soc Nephrol
    2002
    12
    38A
  27. Weiner
    NJ
    ,  
    Goodman
    JW
    ,  
    Kimmel
    PL
    .  
    The HIV-associated renal diseases: Current insight into pathogenesis and treatment
    Kidney Int
    2003
    63
    1618
    31
     PubMed
    CrossRef
     PubMed
  28. Winston
    JA
    ,  
    Klotman
    PE
    .  
    Are we missing an epidemic of HIV-associated nephropathy? [Editorial]
    J Am Soc Nephrol
    1996
    7
    1
    7
     PubMed
     PubMed
  29. Szczech
    LA
    .  
    Renal diseases associated with human immunodeficiency virus infection: epidemiology, clinical course, and management
    Clin Infect Dis
    2001
    33
    115
    9
     PubMed
    CrossRef
     PubMed
  30. Kimmel
    PL
    ,  
    Umana
    WO
    ,  
    Bosch
    JP
    .  
    Abnormal urinary protein excretion in HIV-infected patients
    Clin Nephrol
    1993
    39
    17
    21
     PubMed
     PubMed
  31. Hailemariam
    S
    ,  
    Walder
    M
    ,  
    Burger
    HR
    ,  
    Cathomas
    G
    ,  
    Mihatsch
    M
    ,  
    Binswanger
    U
    ,  
    .  
    Renal pathology and premortem clinical presentation of Caucasian patients with AIDS: an autopsy study from the era prior to antiretroviral therapy
    Swiss Med Wkly
    2001
    131
    412
    7
     PubMed
     PubMed
  32. Szczech
    LA
    ,  
    Gange
    SJ
    ,  
    van der Horst
    C
    ,  
    Bartlett
    JA
    ,  
    Young
    M
    ,  
    Cohen
    MH
    ,  
    .  
    Predictors of proteinuria and renal failure among women with HIV infection
    Kidney Int
    2002
    61
    195
    202
     PubMed
    CrossRef
     PubMed
  33. Gardner
    LI
    ,  
    Holmberg
    SD
    ,  
    Williamson
    JM
    ,  
    Szczech
    LA
    ,  
    Carpenter
    CC
    ,  
    Rompalo
    AM
    ,  
    .  
    Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women
    J Acquir Immune Defic Syndr
    2003
    32
    203
    9
     PubMed
    CrossRef
     PubMed
  34. Mitra
    D
    ,  
    Kim
    J
    ,  
    MacLow
    C
    ,  
    Karsan
    A
    ,  
    Laurence
    J
    .  
    Role of caspases 1 and 3 and Bcl-2-related molecules in endothelial cell apoptosis associated with thrombotic microangiopathies
    Am J Hematol
    1998
    59
    279
    87
     PubMed
    CrossRef
     PubMed
  35. Eitner
    F
    ,  
    Cui
    Y
    ,  
    Hudkins
    KL
    ,  
    Schmidt
    A
    ,  
    Birkebak
    T
    ,  
    Agy
    MB
    ,  
    .  
    Thrombotic microangiopathy in the HIV-2-infected macaque
    Am J Pathol
    1999
    155
    649
    61
     PubMed
    CrossRef
     PubMed
  36. Hymes
    KB
    ,  
    Karpatkin
    S
    .  
    Human immunodeficiency virus infection and thrombotic microangiopathy
    Semin Hematol
    1997
    34
    117
    25
     PubMed
     PubMed
  37. Park
    IW
    ,  
    Ullrich
    CK
    ,  
    Schoenberger
    E
    ,  
    Ganju
    RK
    ,  
    Groopman
    JE
    .  
    HIV-1 Tat induces microvascular endothelial apoptosis through caspase activation
    J Immunol
    2001
    167
    2766
    71
     PubMed
    CrossRef
     PubMed
  38. Sahud
    MA
    ,  
    Claster
    S
    ,  
    Liu
    L
    ,  
    Ero
    M
    ,  
    Harris
    K
    ,  
    Furlan
    M
    .  
    von Willebrand factor-cleaving protease inhibitor in a patient with human immunodeficiency syndrome-associated thrombotic thrombocytopenic purpura
    Br J Haematol
    2002
    116
    909
    11
     PubMed
    CrossRef
     PubMed
  39. Bottieau
    E
    ,  
    Colebunders
    R
    ,  
    Bosmans
    JL
    .  
    Favourable outcome of haemolytic uraemic syndrome in an HIV-infected patient treated only with prednisone [Letter]
    J Infect
    2000
    41
    108
    9
     PubMed
    CrossRef
     PubMed
  40. Sacristn Lista
    F
    ,  
    Saavedra Alonso
    AJ
    ,  
    Oliver Morales
    J
    ,  
    Vzquez Martul
    E
    .  
    Nephrotic syndrome due to thrombotic microangiopathy (TMA) as the first manifestation of human immunodeficiency virus infection: recovery before antiretroviral therapy without specific treatment against TMA
    Clin Nephrol
    2001
    55
    404
    7
     PubMed
     PubMed
  41. Briggs
    WA
    ,  
    Tanawattanacharoen
    S
    ,  
    Choi
    MJ
    ,  
    Scheel
    PJ
    Jr
    ,  
    Nadasdy
    T
    ,  
    Racusen
    L
    .  
    Clinicopathologic correlates of prednisone treatment of human immunodeficiency virus-associated nephropathy
    Am J Kidney Dis
    1996
    28
    618
    21
     PubMed
    CrossRef
     PubMed
  42. Monga
    G
    ,  
    Mazzucco
    G
    ,  
    Boldorini
    R
    ,  
    Cristina
    S
    ,  
    Giacalone
    A
    ,  
    Fortunato
    M
    ,  
    .  
    Renal changes in patients with acquired immunodeficiency syndrome: a post-mortem study on an unselected population in northwestern Italy
    Mod Pathol
    1997
    10
    159
    67
     PubMed
     PubMed
  43. Nochy
    D
    ,  
    Glotz
    D
    ,  
    Dosquet
    P
    ,  
    Pruna
    A
    ,  
    Guettier
    C
    ,  
    Weiss
    L
    ,  
    .  
    Renal disease associated with HIV infection: a multicentric study of 60 patients from Paris hospitals
    Nephrol Dial Transplant
    1993
    8
    11
    9
     PubMed
    CrossRef
     PubMed
  44. Kimmel
    PL
    ,  
    Ferreira-Centeno
    A
    ,  
    Farkas-Szallasi
    T
    ,  
    Abraham
    AA
    ,  
    Garrett
    CT
    .  
    Viral DNA in microdissected renal biopsy tissue from HIV infected patients with nephrotic syndrome
    Kidney Int
    1993
    43
    1347
    52
     PubMed
    CrossRef
     PubMed
  45. Casanova
    S
    ,  
    Mazzucco
    G
    ,  
    Barbiano di Belgiojoso
    G
    ,  
    Motta
    M
    ,  
    Boldorini
    R
    ,  
    Genderini
    A
    ,  
    .  
    Pattern of glomerular involvement in human immunodeficiency virus-infected patients: an Italian study
    Am J Kidney Dis
    1995
    26
    446
    53
     PubMed
    CrossRef
     PubMed
  46. Connolly
    JO
    ,  
    Weston
    CE
    ,  
    Hendry
    BM
    .  
    HIV-associated renal disease in London hospitals
    QJM
    1995
    88
    627
    34
     PubMed
     PubMed
  47. Praditpornsilpa
    K
    ,  
    Napathorn
    S
    ,  
    Yenrudi
    S
    ,  
    Wankrairot
    P
    ,  
    Tungsaga
    K
    ,  
    Sitprija
    V
    .  
    Renal pathology and HIV infection in Thailand
    Am J Kidney Dis
    1999
    33
    282
    6
     PubMed
    CrossRef
     PubMed
  48. Williams
    DI
    ,  
    Williams
    DJ
    ,  
    Williams
    IG
    ,  
    Unwin
    RJ
    ,  
    Griffiths
    MH
    ,  
    Miller
    RF
    .  
    Presentation, pathology, and outcome of HIV associated renal disease in a specialist centre for HIV/AIDS
    Sex Transm Infect
    1998
    74
    179
    84
     PubMed
    CrossRef
     PubMed
  49. Kimmel
    PL
    ,  
    Phillips
    TM
    .  
    Renal and Urologic Aspects of HIV Infection
    New York
    Churchill Livingstone
    1995
    77
    110
  50. Chidambaram
    M
    ,  
    Stigant
    CE
    ,  
    Sugar
    LM
    ,  
    Ramesh Prasad
    GV
    .  
    Type I membranoproliferative glomerulonephritis in an HIV-infected individual without hepatitis C co-infection
    Clin Nephrol
    2002
    57
    154
    7
     PubMed
    CrossRef
     PubMed
  51. Alarcn-Zurita
    A
    ,  
    Salas
    A
    ,  
    Antn
    E
    ,  
    Morey
    A
    ,  
    Munar
    MA
    ,  
    Losada
    P
    ,  
    .  
    Membranous glomerulonephritis with nephrotic syndrome in a HIV positive patientremarkable remission with triple therapy [Letter]
    Nephrol Dial Transplant
    2000
    15
    1097
    8
     PubMed
    CrossRef
     PubMed
  52. Haas
    M
    ,  
    Rajaraman
    S
    ,  
    Ahuja
    T
    ,  
    Kittaka
    M
    ,  
    Cavallo
    T
    .  
    Fibrillary/immunotactoid glomerulonephritis in HIV-positive patients: a report of three cases
    Nephrol Dial Transplant
    2000
    15
    1679
    83
     PubMed
    CrossRef
     PubMed
  53. Cheng
    JT
    ,  
    Anderson
    HL
    Jr
    ,  
    Markowitz
    GS
    ,  
    Appel
    GB
    ,  
    Pogue
    VA
    ,  
    D'Agati
    VD
    .  
    Hepatitis C virus-associated glomerular disease in patients with human immunodeficiency virus coinfection
    J Am Soc Nephrol
    1999
    10
    1566
    74
     PubMed
     PubMed
  54. Stokes
    MB
    ,  
    Chawla
    H
    ,  
    Brody
    RI
    ,  
    Kumar
    A
    ,  
    Gertner
    R
    ,  
    Goldfarb
    DS
    ,  
    .  
    Immune complex glomerulonephritis in patients coinfected with human immunodeficiency virus and hepatitis C virus
    Am J Kidney Dis
    1997
    29
    514
    25
     PubMed
    CrossRef
     PubMed
  55. Guerra
    IL
    ,  
    Abraham
    AA
    ,  
    Kimmel
    PL
    ,  
    Sabnis
    SG
    ,  
    Antonovych
    TT
    .  
    Nephrotic syndrome associated with chronic persistent hepatitis B in an HIV antibody positive patient
    Am J Kidney Dis
    1987
    10
    385
    8
     PubMed
    CrossRef
     PubMed
  56. Korbet
    SM
    ,  
    Schwartz
    MM
    .  
    Human immunodeficiency virus infection and nephrotic syndrome
    Am J Kidney Dis
    1992
    20
    97
    103
     PubMed
    CrossRef
     PubMed
  57. Kimmel
    PL
    ,  
    Phillips
    TM
    ,  
    Ferreira-Centeno
    A
    ,  
    Farkas-Szallasi
    T
    ,  
    Abraham
    AA
    ,  
    Garrett
    CT
    .  
    HIV-associated immune-mediated renal disease
    Kidney Int
    1993
    44
    1327
    40
     PubMed
    CrossRef
     PubMed
  58. Katz
    A
    ,  
    Bargman
    JM
    ,  
    Miller
    DC
    ,  
    Guo
    JW
    ,  
    Ghali
    VS
    ,  
    Schoeneman
    MJ
    .  
    IgA nephritis in HIV-positive patients: a new HIV-associated nephropathy?
    Clin Nephrol
    1992
    38
    61
    8
     PubMed
     PubMed
  59. Kimmel
    PL
    ,  
    Phillips
    TM
    ,  
    Ferreira-Centeno
    A
    ,  
    Farkas-Szallasi
    T
    ,  
    Abraham
    AA
    ,  
    Garrett
    CT
    .  
    Brief report: idiotypic IgA nephropathy in patients with human immunodeficiency virus infection
    N Engl J Med
    1992
    327
    702
    6
     PubMed
    CrossRef
     PubMed
  60. Beaufils
    H
    ,  
    Jouanneau
    C
    ,  
    Katlama
    C
    ,  
    Sazdovitch
    V
    ,  
    Hauw
    JJ
    .  
    HIV-associated IgA nephropathya post-mortem study
    Nephrol Dial Transplant
    1995
    10
    35
    8
     PubMed
    CrossRef
     PubMed
  61. Donadio
    JV
    ,  
    Grande
    JP
    .  
    IgA nephropathy
    N Engl J Med
    2002
    347
    738
    48
     PubMed
    CrossRef
     PubMed
  62. Freedman
    BI
    ,  
    Soucie
    JM
    ,  
    Stone
    SM
    ,  
    Pegram
    S
    .  
    Familial clustering of end-stage renal disease in blacks with HIV-associated nephropathy
    Am J Kidney Dis
    1999
    34
    254
    8
     PubMed
    CrossRef
     PubMed
  63. Grriz
    JL
    ,  
    Rovira
    E
    ,  
    Sancho
    A
    ,  
    Ferrer
    R
    ,  
    Paricio
    A
    ,  
    Pallard
    LM
    .  
    IgA nephropathy associated with human immuno deficiency virus infection: antiproteinuric effect of captopril [Letter]
    Nephrol Dial Transplant
    1997
    12
    2796
    7
     PubMed
    CrossRef
     PubMed
  64. Boix
    E
    ,  
    Rivera
    F
    ,  
    Gil
    CM
    ,  
    Prez-Contreras
    J
    ,  
    Olivares
    J
    .  
    Steroid-responsive nephrotic syndrome with minimal-change disease and IgA deposits in a HIV-infected patient
    Nephrol Dial Transplant
    2000
    15
    412
    4
     PubMed
    CrossRef
     PubMed
  65. Mattana
    J
    ,  
    Siegal
    FP
    ,  
    Schwarzwald
    E
    ,  
    Molho
    L
    ,  
    Sankaran
    RT
    ,  
    Gooneratne
    R
    ,  
    .  
    AIDS-associated membranous nephropathy with advanced renal failure: response to prednisone
    Am J Kidney Dis
    1997
    30
    116
    9
     PubMed
    CrossRef
     PubMed
  66. Bourgoignie
    JJ
    .  
    Renal complications of human immunodeficiency virus type 1
    Kidney Int
    1990
    37
    1571
    84
     PubMed
    CrossRef
     PubMed
  67. Klotman
    PE
    .  
    HIV-associated nephropathy
    Kidney Int
    1999
    56
    1161
    76
     PubMed
    CrossRef
     PubMed
  68. D'Agati
    V
    ,  
    Appel
    GB
    .  
    HIV infection and the kidney
    J Am Soc Nephrol
    1997
    8
    138
    52
     PubMed
     PubMed
  69. Winston
    JA
    ,  
    Klotman
    ME
    ,  
    Klotman
    PE
    .  
    HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection
    Kidney Int
    1999
    55
    1036
    40
     PubMed
    CrossRef
     PubMed
  70. Wali
    RK
    ,  
    Drachenberg
    CI
    ,  
    Papadimitriou
    JC
    ,  
    Keay
    S
    ,  
    Ramos
    E
    .  
    HIV-1-associated nephropathy and response to highly-active antiretroviral therapy [Letter]
    Lancet
    1998
    352
    783
    4
     PubMed
    CrossRef
     PubMed
  71. Levin
    ML
    ,  
    Palella
    F
    ,  
    Shah
    S
    ,  
    Lerma
    E
    ,  
    Butter
    J
    ,  
    Kanwar
    YS
    .  
    Hiv-associated nephropathy occurring before HIV antibody seroconversion
    Am J Kidney Dis
    2001
    37
    E39
     PubMed
    CrossRef
     PubMed
  72. Winston
    JA
    ,  
    Bruggeman
    LA
    ,  
    Ross
    MD
    ,  
    Jacobson
    J
    ,  
    Ross
    L
    ,  
    D'Agati
    VD
    ,  
    .  
    Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection
    N Engl J Med
    2001
    344
    1979
    84
     PubMed
    CrossRef
     PubMed
  73. Cohen
    AH
    ,  
    Nast
    CC
    .  
    HIV-associated nephropathy. A unique combined glomerular, tubular, and interstitial lesion
    Mod Pathol
    1988
    1
    87
    97
     PubMed
     PubMed
  74. D'Agati
    V
    ,  
    Appel
    GB
    .  
    Renal pathology of human immunodeficiency virus infection
    Semin Nephrol
    1998
    18
    406
    21
     PubMed
     PubMed
  75. Strauss
    J
    ,  
    Abitbol
    C
    ,  
    Zilleruelo
    G
    ,  
    Scott
    G
    ,  
    Paredes
    A
    ,  
    Malaga
    S
    ,  
    .  
    Renal disease in children with the acquired immunodeficiency syndrome
    N Engl J Med
    1989
    321
    625
    30
     PubMed
    CrossRef
     PubMed
  76. Kopp
    JB
    ,  
    Klotman
    ME
    ,  
    Adler
    SH
    ,  
    Bruggeman
    LA
    ,  
    Dickie
    P
    ,  
    Marinos
    NJ
    ,  
    .  
    Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes
    Proc Natl Acad Sci U S A
    1992
    89
    1577
    81
     PubMed
    CrossRef
     PubMed
  77. Reid
    W
    ,  
    Sadowska
    M
    ,  
    Denaro
    F
    ,  
    Rao
    S
    ,  
    Foulke
    J
    Jr
    ,  
    Hayes
    N
    ,  
    .  
    An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction
    Proc Natl Acad Sci U S A
    2001
    98
    9271
    6
     PubMed
    CrossRef
     PubMed
  78. Alpers
    CE
    ,  
    Tsai
    CC
    ,  
    Hudkins
    KL
    ,  
    Cui
    Y
    ,  
    Kuller
    L
    ,  
    Benveniste
    RE
    ,  
    .  
    Focal segmental glomerulosclerosis in primates infected with a simian immunodeficiency virus
    AIDS Res Hum Retroviruses
    1997
    13
    413
    24
     PubMed
    CrossRef
     PubMed
  79. Stephens
    EB
    ,  
    Tian
    C
    ,  
    Dalton
    SB
    ,  
    Gattone
    VH
    2nd
    .  
    Simian-human immunodeficiency virus-associated nephropathy in macaques
    AIDS Res Hum Retroviruses
    2000
    16
    1295
    306
     PubMed
    CrossRef
     PubMed
  80. Marras
    D
    ,  
    Bruggeman
    LA
    ,  
    Gao
    F
    ,  
    Tanji
    N
    ,  
    Mansukhani
    MM
    ,  
    Cara
    A
    ,  
    .  
    Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy
    Nat Med
    2002
    8
    522
    6
     PubMed
    CrossRef
     PubMed
  81. Bruggeman
    LA
    ,  
    Ross
    MD
    ,  
    Tanji
    N
    ,  
    Cara
    A
    ,  
    Dikman
    S
    ,  
    Gordon
    RE
    ,  
    .  
    Renal epithelium is a previously unrecognized site of HIV-1 infection
    J Am Soc Nephrol
    2000
    11
    2079
    87
     PubMed
     PubMed
  82. Ross
    MJ
    ,  
    Klotman
    PE
    .  
    Recent progress in HIV-associated nephropathy
    J Am Soc Nephrol
    2002
    13
    2997
    3004
     PubMed
    CrossRef
     PubMed
  83. Bodi
    I
    ,  
    Abraham
    AA
    ,  
    Kimmel
    PL
    .  
    Macrophages in HIV nephropathy
    Am J Kidney Dis
    1994
    24
    762
    767
    CrossRef
     PubMed
  84. Segerer
    S
    ,  
    Nelson
    PJ
    ,  
    Schlndorff
    D
    .  
    Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies
    J Am Soc Nephrol
    2000
    11
    152
    76
     PubMed
     PubMed
  85. Kinter
    A
    ,  
    Arthos
    J
    ,  
    Cicala
    C
    ,  
    Fauci
    AS
    .  
    Chemokines, cytokines and HIV: a complex network of interactions that influence HIV pathogenesis
    Immunol Rev
    2000
    177
    88
    98
     PubMed
    CrossRef
     PubMed
  86. Carrington
    M
    ,  
    Dean
    M
    ,  
    Martin
    MP
    ,  
    O'Brien
    SJ
    .  
    Genetics of HIV-1 infection: chemokine receptor CCR5 polymorphism and its consequences
    Hum Mol Genet
    1999
    8
    1939
    45
     PubMed
    CrossRef
     PubMed
  87. Conaldi
    PG
    ,  
    Biancone
    L
    ,  
    Bottelli
    A
    ,  
    Wade-Evans
    A
    ,  
    Racusen
    LC
    ,  
    Boccellino
    M
    ,  
    .  
    HIV-1 kills renal tubular epithelial cells in vitro by triggering an apoptotic pathway involving caspase activation and Fas upregulation
    J Clin Invest
    1998
    102
    2041
    9
     PubMed
    CrossRef
     PubMed
  88. Huber
    TB
    ,  
    Reinhardt
    HC
    ,  
    Exner
    M
    ,  
    Burger
    JA
    ,  
    Kerjaschki
    D
    ,  
    Saleem
    MA
    ,  
    .  
    Expression of functional CCR and CXCR chemokine receptors in podocytes
    J Immunol
    2002
    168
    6244
    52
     PubMed
    CrossRef
     PubMed
  89. Eitner
    F
    ,  
    Cui
    Y
    ,  
    Hudkins
    KL
    ,  
    Stokes
    MB
    ,  
    Segerer
    S
    ,  
    Mack
    M
    ,  
    .  
    Chemokine receptor CCR5 and CXCR4 expression in HIV-associated kidney disease
    J Am Soc Nephrol
    2000
    11
    856
    67
     PubMed
     PubMed
  90. Bdi
    I
    ,  
    Kimmel
    PL
    ,  
    Abraham
    AA
    ,  
    Svetkey
    LP
    ,  
    Klotman
    PE
    ,  
    Kopp
    JB
    .  
    Renal TGF- in HIV-associated kidney diseases
    Kidney Int
    1997
    51
    1568
    77
     PubMed
    CrossRef
     PubMed
  91. Kimmel
    PL
    ,  
    Cohen
    DJ
    ,  
    Abraham
    AA
    ,  
    Bodi
    I
    ,  
    Schwartz
    AM
    ,  
    Phillips
    TM
    .  
    Upregulation of MHC class II, interferon- and interferon- receptor protein expression in HIV-associated nephropathy
    Nephrol Dial Transplant
    2003
    18
    285
    92
     PubMed
    CrossRef
     PubMed
  92. Bdi
    I
    ,  
    Abraham
    AA
    ,  
    Kimmel
    PL
    .  
    Apoptosis in human immunodeficiency virus-associated nephropathy
    Am J Kidney Dis
    1995
    26
    286
    91
     PubMed
    CrossRef
     PubMed
  93. Bruggeman
    LA
    ,  
    Dikman
    S
    ,  
    Meng
    C
    ,  
    Quaggin
    SE
    ,  
    Coffman
    TM
    ,  
    Klotman
    PE
    .  
    Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression
    J Clin Invest
    1997
    100
    84
    92
     PubMed
    CrossRef
     PubMed
  94. Kimmel
    PL
    ,  
    Bosch
    JP
    ,  
    Vassalotti
    JA
    .  
    Treatment of human immunodeficiency virus (HIV)-associated nephropathy
    Semin Nephrol
    1998
    18
    446
    58
     PubMed
     PubMed
  95. Smith
    MC
    ,  
    Austen
    JL
    ,  
    Carey
    JT
    ,  
    Emancipator
    SN
    ,  
    Herbener
    T
    ,  
    Gripshover
    B
    ,  
    .  
    Prednisone improves renal function and proteinuria in human immunodeficiency virus-associated nephropathy
    Am J Med
    1996
    101
    41
    8
     PubMed
    CrossRef
     PubMed
  96. Sothinathan
    R
    ,  
    Briggs
    WA
    ,  
    Eustace
    JA
    .  
    Treatment of HIV-associated nephropathy
    AIDS Patient Care STDS
    2001
    15
    363
    71
     PubMed
    CrossRef
     PubMed
  97. Winston
    JA
    ,  
    Burns
    GC
    ,  
    Klotman
    PE
    .  
    Treatment of HIV-associated nephropathy
    Semin Nephrol
    2000
    20
    293
    8
     PubMed
     PubMed
  98. Eustace
    JA
    ,  
    Nuermberger
    E
    ,  
    Choi
    M
    ,  
    Scheel
    PJ
    Jr
    ,  
    Moore
    R
    ,  
    Briggs
    WA
    .  
    Cohort study of the treatment of severe HIV-associated nephropathy with corticosteroids
    Kidney Int
    2000
    58
    1253
    60
     PubMed
    CrossRef
     PubMed
  99. Kimmel
    PL
    ,  
    Mishkin
    GJ
    ,  
    Umana
    WO
    .  
    Captopril and renal survival in patients with human immunodeficiency virus nephropathy
    Am J Kidney Dis
    1996
    28
    202
    8
     PubMed
    CrossRef
     PubMed
  100. Burns
    GC
    ,  
    Paul
    SK
    ,  
    Toth
    IR
    ,  
    Sivak
    SL
    .  
    Effect of angiotensin-converting enzyme inhibition in HIV-associated nephropathy
    J Am Soc Nephrol
    1997
    8
    1140
    6
     PubMed
     PubMed
  101. Bird
    JE
    ,  
    Durham
    SK
    ,  
    Giancarli
    MR
    ,  
    Gitlitz
    PH
    ,  
    Pandya
    DG
    ,  
    Dambach
    DM
    ,  
    .  
    Captopril prevents nephropathy in HIV-transgenic mice
    J Am Soc Nephrol
    1998
    9
    1441
    7
     PubMed
     PubMed
  102. Cosgrove
    CJ
    ,  
    Abu-Alfa
    AK
    ,  
    Perazella
    MA
    .  
    Observations on HIV-associated renal disease in the era of highly active antiretroviral therapy
    Am J Med Sci
    2002
    323
    102
    6
     PubMed
    CrossRef
     PubMed
  103. Kirchner
    JT
    .  
    Resolution of renal failure after initiation of HAART: 3 cases and a discussion of the literature
    AIDS Read
    2002
    12
    103
    5, 110-2
     PubMed
     PubMed
  104. Szczech
    LA
    ,  
    Edwards
    LJ
    ,  
    Sanders
    LL
    ,  
    van der Horst
    C
    ,  
    Bartlett
    JA
    ,  
    Heald
    AE
    ,  
    .  
    Protease inhibitors are associated with a slowed progression of HIV-related renal diseases
    Clin Nephrol
    2002
    57
    336
    41
     PubMed
    CrossRef
     PubMed
  105. Ahuja
    TS
    ,  
    Borucki
    M
    ,  
    Grady
    J
    .  
    Highly active antiretroviral therapy improves survival of HIV-infected hemodialysis patients
    Am J Kidney Dis
    2000
    36
    574
    80
     PubMed
    CrossRef
     PubMed
  106. Ahuja
    TS
    ,  
    Grady
    J
    ,  
    Khan
    S
    .  
    Changing trends in the survival of dialysis patients with human immunodeficiency virus in the United States
    J Am Soc Nephrol
    2002
    13
    1889
    93
     PubMed
    CrossRef
     PubMed
  107. Gow
    PJ
    ,  
    Pillay
    D
    ,  
    Mutimer
    D
    .  
    Solid organ transplantation in patients with HIV infection
    Transplantation
    2001
    72
    177
    81
     PubMed
    CrossRef
     PubMed
  108. Murphy
    B
    ,  
    Carlson
    L
    ,  
    Rohal
    S
    ,  
    Keller
    M
    ,  
    Lu
    A
    ,  
    Kumar
    MSA
    ,  
    .  
    Renal transplantation in HIV-infected recipients: twenty-three cases in the HAART era [Abstract]
    J Am Soc Nephrol
    2002
    13
    11A
  109. Halpern
    SD
    ,  
    Ubel
    PA
    ,  
    Caplan
    AL
    .  
    Solid-organ transplantation in HIV-infected patients
    N Engl J Med
    2002
    347
    284
    7
     PubMed
    CrossRef
     PubMed
  110. Kuo
    PC
    ,  
    Stock
    PG
    .  
    Transplantation in the HIV+ patient
    Am J Transplant
    2001
    1
    13
    7
     PubMed
    CrossRef
     PubMed
  111. Roland
    ME
    ,  
    Stock
    PG
    .  
    Review of solid-organ transplantation in HIV-infected patients
    Transplantation
    2003
    75
    425
    9
     PubMed
    CrossRef
     PubMed
  112. Dybul
    M
    ,  
    Fauci
    AS
    ,  
    Bartlett
    JG
    ,  
    Kaplan
    JE
    ,  
    Pau
    AK
    .  
    Guidelines for using antiretroviral agents among HIV-infected adults and adolescents
    Ann Intern Med
    2002
    137
    381
    433
    CrossRef
     PubMed
  113. Klotman
    P
    ,  
    Klotman
    M
    .  
    Editorial comment: renal insufficiency in HIV-infected patients may not always be HIVAN
    AIDS Read
    2002
    12
    273
     PubMed
     PubMed
  114. Valeri
    A
    ,  
    Barisoni
    L
    ,  
    Appel
    GB
    ,  
    Seigle
    R
    ,  
    D'Agati
    V
    .  
    Idiopathic collapsing focal segmental glomerulosclerosis: a clinicopathologic study
    Kidney Int
    1996
    50
    1734
    46
     PubMed
    CrossRef
     PubMed
  115. D'Agati
    V
    .  
    The many masks of focal segmental glomerulosclerosis
    Kidney Int
    1994
    46
    1223
    41
     PubMed
    CrossRef
     PubMed
  116. Schwartz
    MM
    ,  
    Korbet
    SM
    ,  
    Rydell
    J
    ,  
    Borok
    R
    ,  
    Genchi
    R
    .  
    Primary focal segmental glomerular sclerosis in adults: prognostic value of histologic variants
    Am J Kidney Dis
    1995
    25
    845
    52
     PubMed
    CrossRef
     PubMed
  117. Schwimmer
    JA
    ,  
    Markowitz
    GS
    ,  
    Valeri
    A
    ,  
    Appel
    GB
    .  
    Collapsing glomerulopathy
    Semin Nephrol
    2003
    23
    209
    18
     PubMed
    CrossRef
     PubMed
  118. Barisoni
    L
    ,  
    Kriz
    W
    ,  
    Mundel
    P
    ,  
    D'Agati
    V
    .  
    The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy
    J Am Soc Nephrol
    1999
    10
    51
    61
     PubMed
     PubMed
  119. Barisoni
    L
    ,  
    Bruggeman
    LA
    ,  
    Mundel
    P
    ,  
    D'Agati
    VD
    ,  
    Klotman
    PE
    .  
    HIV-1 induces renal epithelial dedifferentiation in a transgenic model of HIV-associated nephropathy
    Kidney Int
    2000
    58
    173
    81
     PubMed
    CrossRef
     PubMed
  120. Barity
    J
    ,  
    Nochy
    D
    ,  
    Mandet
    C
    ,  
    Jacquot
    C
    ,  
    Glotz
    D
    ,  
    Meyrier
    A
    .  
    Podocytes undergo phenotypic changes and express macrophagic-associated markers in idiopathic collapsing glomerulopathy
    Kidney Int
    1998
    53
    918
    25
     PubMed
    CrossRef
     PubMed
  121. Barisoni
    L
    ,  
    Mokrzycki
    M
    ,  
    Sablay
    L
    ,  
    Nagata
    M
    ,  
    Yamase
    H
    ,  
    Mundel
    P
    .  
    Podocyte cell cycle regulation and proliferation in collapsing glomerulopathies
    Kidney Int
    2000
    58
    137
    43
     PubMed
    CrossRef
     PubMed
  122. Shankland
    SJ
    ,  
    Eitner
    F
    ,  
    Hudkins
    KL
    ,  
    Goodpaster
    T
    ,  
    D'Agati
    V
    ,  
    Alpers
    CE
    .  
    Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: role in podocyte proliferation and maturation
    Kidney Int
    2000
    58
    674
    83
     PubMed
    CrossRef
     PubMed
  123. Barisoni
    L
    ,  
    Kopp
    JB
    .  
    Modulation of podocyte phenotype in collapsing glomerulopathies
    Microsc Res Tech
    2002
    57
    254
    62
     PubMed
    CrossRef
     PubMed
  124. Dickie
    P
    ,  
    Felser
    J
    ,  
    Eckhaus
    M
    ,  
    Bryant
    J
    ,  
    Silver
    J
    ,  
    Marinos
    N
    ,  
    .  
    HIV-associated nephropathy in transgenic mice expressing HIV-1 genes
    Virology
    1991
    185
    109
    19
     PubMed
    CrossRef
     PubMed
  125. Ross
    MJ
    ,  
    Bruggeman
    LA
    ,  
    Wilson
    PD
    ,  
    Klotman
    PE
    .  
    Microcyst formation and HIV-1 gene expression occur in multiple nephron segments in HIV-associated nephropathy
    J Am Soc Nephrol
    2001
    12
    2645
    51
     PubMed
     PubMed
  126. Bauer
    FA
    ,  
    Wear
    DJ
    ,  
    Angritt
    P
    ,  
    Lo
    SC
    .  
    Mycoplasma fermentans (incognitus strain) infection in the kidneys of patients with acquired immunodeficiency syndrome and associated nephropathy: a light microscopic, immunohistochemical, and ultrastructural study
    Hum Pathol
    1991
    22
    63
    9
     PubMed
    CrossRef
     PubMed
  127. Li
    RM
    ,  
    Branton
    MH
    ,  
    Tanawattanacharoen
    S
    ,  
    Falk
    RA
    ,  
    Jennette
    JC
    ,  
    Kopp
    JB
    .  
    Molecular identification of SV40 infection in human subjects and possible association with kidney disease
    J Am Soc Nephrol
    2002
    13
    2320
    30
     PubMed
    CrossRef
     PubMed
  128. Yamamoto
    T
    ,  
    Noble
    NA
    ,  
    Cohen
    AH
    ,  
    Nast
    CC
    ,  
    Hishida
    A
    ,  
    Gold
    LI
    ,  
    .  
    Expression of transforming growth factor- isoforms in human glomerular diseases
    Kidney Int
    1996
    49
    461
    9
     PubMed
    CrossRef
     PubMed
  129. Ray
    PE
    ,  
    Liu
    XH
    ,  
    Henry
    D
    ,  
    Dye
    L
    3rd
    ,  
    Xu
    L
    ,  
    Orenstein
    JM
    ,  
    .  
    Infection of human primary renal epithelial cells with HIV-1 from children with HIV-associated nephropathy
    Kidney Int
    1998
    53
    1217
    29
     PubMed
    CrossRef
     PubMed
  130. Green
    DF
    ,  
    Resnick
    L
    ,  
    Bourgoignie
    JJ
    .  
    HIV infects glomerular endothelial and mesangial but not epithelial cells in vitro
    Kidney Int
    1992
    41
    956
    60
     PubMed
    CrossRef
     PubMed
  131. Alpers
    CE
    ,  
    McClure
    J
    ,  
    Bursten
    SL
    .  
    Human mesangial cells are resistant to productive infection by multiple strains of human immunodeficiency virus types 1 and 2
    Am J Kidney Dis
    1992
    19
    126
    30
     PubMed
    CrossRef
     PubMed
  132. Tokizawa
    S
    ,  
    Shimizu
    N
    ,  
    Hui-Yu
    L
    ,  
    Deyu
    F
    ,  
    Haraguchi
    Y
    ,  
    Oite
    T
    ,  
    .  
    Infection of mesangial cells with HIV and SIV: identification of GPR1 as a coreceptor
    Kidney Int
    2000
    58
    607
    17
     PubMed
    CrossRef
     PubMed
  133. Cohen
    AH
    ,  
    Sun
    NC
    ,  
    Shapshak
    P
    ,  
    Imagawa
    DT
    .  
    Demonstration of human immunodeficiency virus in renal epithelium in HIV-associated nephropathy
    Mod Pathol
    1989
    2
    125
    8
     PubMed
     PubMed
  134. Kimmel
    PL
    ,  
    Phillips
    TM
    ,  
    Tinkle
    BT
    ,  
    Jay
    G
    .  
    HIV accessory proteins and transforming growth factor-1 are associated with nephropathy in a transgenic mouse model [Abstract]
    J Invest Med
    1996
    44
    321A
  135. Kajiyama
    W
    ,  
    Klotman
    PE
    ,  
    Dickie
    P
    ,  
    Kopp
    JB
    .  
    HIV-1 genes are expressed in glomerular and tubular epithelial cells in HIV-transgenic mouse kidney
    AIDS Res Hum Retroviruses
    1995
    11
    S153
  136. Hanna
    Z
    ,  
    Kay
    DG
    ,  
    Rebai
    N
    ,  
    Guimond
    A
    ,  
    Jothy
    S
    ,  
    Jolicoeur
    P
    .  
    Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice
    Cell
    1998
    95
    163
    75
     PubMed
    CrossRef
     PubMed
  137. Kopp
    JB
    ,  
    Winkler
    CA
    .  
    HIV-associated nephropathy in African Americans
    Kidney Int
    2003
    63
    S43
    9
    CrossRef
  138. Kopp
    JB
    ,  
    Vlahov
    D
    ,  
    Macalino
    G
    ,  
    .  
    Candidate gene analysis in focal segmental glomerulosclerosis among African-Americans [Abstract]
    J Am Soc Nephrol
    1998
    9
    A1997
  139. Marre
    M
    ,  
    Jeunemaitre
    X
    ,  
    Gallois
    Y
    ,  
    Rodier
    M
    ,  
    Chatellier
    G
    ,  
    Sert
    C
    ,  
    .  
    Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group
    J Clin Invest
    1997
    99
    1585
    95
     PubMed
    CrossRef
     PubMed
  140. Yoshida
    H
    ,  
    Mitarai
    T
    ,  
    Kawamura
    T
    ,  
    Kitajima
    T
    ,  
    Miyazaki
    Y
    ,  
    Nagasawa
    R
    ,  
    .  
    Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy
    J Clin Invest
    1995
    96
    2162
    9
     PubMed
    CrossRef
     PubMed
  141. Lee
    DY
    ,  
    Kim
    W
    ,  
    Kang
    SK
    ,  
    Koh
    GY
    ,  
    Park
    SK
    .  
    Angiotensin-converting enzyme gene polymorphism in patients with minimal-change nephrotic syndrome and focal segmental glomerulosclerosis
    Nephron
    1997
    77
    471
    3
     PubMed
    CrossRef
     PubMed
  142. Hori
    C
    ,  
    Hiraoka
    M
    ,  
    Yoshikawa
    N
    ,  
    Tsuzuki
    K
    ,  
    Yoshida
    Y
    ,  
    Yoshioka
    K
    ,  
    .  
    Significance of ACE genotypes and medical treatments in childhood focal glomerulosclerosis
    Nephron
    2001
    88
    313
    9
     PubMed
    CrossRef
     PubMed
  143. Bloem
    LJ
    ,  
    Manatunga
    AK
    ,  
    Pratt
    JH
    .  
    Racial difference in the relationship of an angiotensin I-converting enzyme gene polymorphism to serum angiotensin I-converting enzyme activity
    Hypertension
    1996
    27
    62
    6
     PubMed
    CrossRef
     PubMed
Figure 1.

Percentage of HIV-infected patients receiving hemodialysis in the U.S. hemodialysis program

Figure 2.

Interferon- protein expression in renal tissue compartmentsPP

Figure 3.

Histopathologic characteristics of HIV-associated nephropathy in humans and transgenic mice.A.B.C.PasterisksD and E.DEDEF and G.FGbrown

Figure 4.

Model for glomerular and tubular cell injury induced by HIV-1

Table. HIV-1 Transgenic Mice with Renal Disease

Table. HIV-1 Transgenic Mice with Renal Disease

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

This feature is available only to Registered Users

Subscribe/Learn More
Submit a Comment

0 Comments

PDF
Not Available
Citations
Citation

Kimmel PL, Barisoni L, Kopp JB. Pathogenesis and Treatment of HIV-Associated Renal Diseases: Lessons from Clinical and Animal Studies, Molecular Pathologic Correlations, and Genetic Investigations. Ann Intern Med. 2003;139:214–226. doi: https://doi.org/10.7326/0003-4819-139-3-200308050-00011

Download citation file:

  • Ris (Zotero)
  • EndNote
  • BibTex
  • Medlars
  • ProCite
  • RefWorks
  • Reference Manager

© 2019

×
Permissions

Published: Ann Intern Med. 2003;139(3):214-226.

DOI: 10.7326/0003-4819-139-3-200308050-00011

104 Citations

See Also

Prevalence of bcl-2 Rearrangement in Patients with Hepatitis C Virus–Related Mixed Cryoglobulinemia with or without B-Cell Lymphomas
View MoreView Less
CME/MOC Activity Requires Users to be Registered and Logged In.
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
Annals of Internal Medicine
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
The Comments Feature Requires Users to be Registered and Logged In.
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
Annals of Internal Medicine
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
link to top

Content

  • Home
  • Latest
  • Issues
  • Channels
  • CME/MOC
  • In the Clinic
  • Journal Club
  • Web Exclusives

Information For

  • Author Info
  • Reviewers
  • Press
  • Readers
  • Institutions / Libraries / Agencies
  • Advertisers

Services

  • Subscribe
  • Renew
  • Alerts
  • Current Issue RSS
  • Latest RSS
  • In the Clinic RSS
  • Reprints & Permissions
  • Contact Us
  • Help
  • About Annals
  • About Mobile
  • Patient Information
  • Teaching Tools
  • Annals in the News
  • Share Your Feedback

Awards and Cover

  • Personae (Cover Photo)
  • Junior Investigator Awards
  • Poetry Prize

Other Resources

  • ACP Online
  • Career Connection
  • ACP Advocate Blog
  • ACP Journal Wise

Follow Annals On

  • Twitter Link
  • Facebook Link
acp link acp
silverchair link silverchair

Copyright © 2019 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
INSTITUTIONAL SIGN IN
Open Athens|Shibboleth|Log In
Annals of Internal Medicine
PURCHASE OPTIONS
Buy This Article|Subscribe
You will be redirected to acponline.org to sign-in to Annals to complete your purchase.
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
Annals of Internal Medicine
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×